scPharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -403%. Total operating expenses were $65,178,000.
Profit Margin
| 2015 | 0 | -10.51M | |
|---|---|---|---|
| 2016 | 0 | -24.37M | |
| 2017 | 0 | -23.81M | |
| 2018 | 0 | -29.44M | |
| 2019 | 0 | -34.41M | |
| 2020 | 0 | -34.39M | |
| 2021 | 0 | -30.48M | |
| 2022 | 0 | -37.51M | |
| 2023 | 13.59M | -54.81M | -403.22% |
SCPH Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 13.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.81M | 468K | 438K | 399K | 364K | 0 | 167K | 0 | 4K |
Gross profit | 9.78M | -468K | -438K | -399K | -364K | 0 | -167K | 0 | -4K |
Operating exp. | |||||||||
Research and development | 11.80M | 15.53M | 16.03M | 18.14M | 24.63M | 15.94M | 14.33M | 11.85M | 8.26M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 65.17M | 36.15M | 25.82M | 29.93M | 32.90M | 29.66M | 23.43M | 17.91M | 10.84M |
Operating income | -55.39M | -36.15M | -25.82M | -29.93M | -32.90M | -29.66M | -23.43M | -17.91M | -10.84M |
Other income (expenses), net | 586K | -681K | -2.21M | -2.27M | -91K | -56K | -381K | 38K | 326K |
Income before tax | -54.81M | -36.83M | -28.03M | -32.20M | -32.99M | -29.44M | -23.81M | -24.37M | -10.51M |
Income tax expense | 0 | 681K | 2.45M | 2.18M | 1.41M | -224K | 381K | 6.46M | -326K |
Net income | -54.81M | -37.51M | -30.48M | -34.39M | -34.41M | -29.44M | -23.81M | -24.37M | -10.51M |
Earnings per share | |||||||||
Basic EPS | -1.42 | -1.32 | -1.11 | -1.4 | -1.85 | -1.59 | -8.04 | -2.18 | -0.94 |
Diluted EPS | -1.42 | -1.32 | -1.11 | -1.4 | -1.85 | -1.59 | -8.04 | -2.18 | -0.94 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |